Regencell Bioscience Holdings, a Hong Kong-based company dabbling in traditional Chinese medicine (TCM), has recently taken the stock market by storm, boasting an astronomical leap in share prices that can only be described as speculative mania. With no revenue to speak of and a track record that invites skepticism, the company’s surge—peaking at over 58,000%
Finance
China’s economy has recently witnessed an uptick in retail sales growth, with May’s figures rising by an impressive 6.4% compared to the same month last year. For many, this spike might seem like a sign of recovery in the world’s second-largest economy, especially considering the dismal backdrop of ongoing deflation and sluggish growth. But is
In a time when energy demand is reaching unprecedented heights, the spotlight shines brighter than ever on uranium as a viable power source. John Ciampaglia, the CEO of Sprott Asset Management, asserts that we’re witnessing a transformative shift in the perception of nuclear energy. This perspective is not only timely but reflects a growing need
In an audacious display of confidence, Chinese enterprises are charting a bold course into the global marketplace, propelled by a desire to establish their brands and reach far beyond their domestic borders. The recent stock listing of Insta360 on Shanghai’s STAR board serves as a striking emblem of this trend. With a staggering raise of
The recent agreement between the United States and China represents more than a mere negotiation outcome; it symbolizes a tenuous truce in a longstanding economic war that has raged on for years. As Commerce Secretary Howard Lutnick of the U.S. and China’s Vice Minister of Commerce, Li Chenggang, announced their newfound “framework” in the heart
In a climate of economic uncertainty and geopolitical tension, the insights of influential financial figures like Jeffrey Gundlach cannot be overlooked. As the CEO of DoubleLine Capital, Gundlach’s perspective offers a critical lens through which we can assess the current investing landscape. His clear stance is that U.S. equities are likely to underperform compared to
Walmart’s recent venture into the financial services sector exemplifies a pivotal shift in strategy that must be examined closely. With its majority-owned fintech startup, OnePay, the retail giant is not only embracing the financial landscape but also aiming to disrupt it. The launch of two new credit cards in partnership with Synchrony marks a significant
Generation Z is grappling with a staggering financial quandary that transcends mere mismanagement; it is rooted in a deep-seated sense of hopelessness. According to a recent Credit Karma poll, close to 49% of adults within this demographic, primarily those in their late twenties, feel that preparing for the future is an exercise in futility. The
In today’s rapidly evolving technological landscape, rare earth elements (REEs) serve as the backbone of many high-tech industries, including automotive, defense, and consumer electronics. As the world becomes increasingly reliant on these precious resources, the significance of their supply chain cannot be overstated. Unfortunately, this dependency has delivered a stunning blow to modern industry as
The discourse surrounding U.S.-China rivalry often revolves around artificial intelligence, overshadowing an equally significant race: biotechnology. Emerging reports reveal that China is not merely advancing; it is poised to potentially eclipse the United States in this critical sector. The Harvard Belfer Center for Science and International Affairs has highlighted that of the five key technology